LIVE CELL IMAGING MARKET ANALYSIS

Regional Analysis

Global Live Cell Imaging Market: Regional Insights

Based on geography, the global live cell imaging market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period due to the increasing prevalence of cancer in this region, especially in the United States. The use of live cell imaging has increased owing to the rising incidence of cancer in the U.S. For instance, according to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.

Europe is also expected to witness robust growth in the global live cell imaging market due to the rising incidence of chronic disease (such as cancer, neurodegeneration, & cardiac diseases) and rising government funding. The Cancer Research UK and Wellcome Trust are increasingly funding research in cell and developmental biology. Universities and private research institutes are also making the technology more accessible to yield faster results.

Figure 1. Global Live Cell Imaging Market Share (%), by Region, 2021

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa